Abbott Laboratories $ABT, a leading company in the medical equipment and diagnostics sector, has announced significant plans to expand its manufacturing operations in the United States. In light of the growing impact of tariffs on the industry, the company intends to invest $500 million in the modernization and development of two facilities located in Illinois and Texas. This decision reflects Abbott's commitment not only to adapt to new economic realities but also to maintain its leadership by supporting innovation and product quality.

Investor AB, an investment company controlled by the influential Swedish Wallenberg family, has announced its acquisition of medical equipment manufacturer Nova Biomedical for $2.2 billion. This deal opens exciting opportunities for both companies and expands their presence in the medical instrument market.